Brickell Biotech, Inc. (BBI) Tops Q2 EPS by $1.43

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. DOX
4. BKNG
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. FISV

Go back to Brickell Biotech, Inc. (BBI) Tops Q2 EPS by $1.43

Brickell Biotech Reports Second Quarter 2022 Financial Results and Provides Corporate Update

August 11, 2022 4:05 PM EDT

Phase 1 study of BBI-02 progressing well and expect to initiate MAD part of the study next month

On track to report SAD and MAD topline results from BBI-02 Phase 1 study by early 2023

Development of BBI-10 and next-generation kinase inhibitors advancing through early preclinical stage studies

BOULDER, Colo., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (Brickell or the Company) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmune,... More